A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
Authors
Keywords
-
Journal
Clinical Case Reports
Volume 9, Issue 9, Pages -
Publisher
Wiley
Online
2021-09-18
DOI
10.1002/ccr3.4805
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study
- (2020) Fang-Xiao Zhu et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of thrombotic events in patients with immune thrombocytopenia
- (2019) Shoko Ito et al. ANNALS OF HEMATOLOGY
- Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist–oncologists
- (2018) Allyson M. Pishko et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score
- (2018) Amaris K. Balitsky et al. BLOOD
- Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: An NIS study
- (2018) Nicoletta Machin et al. THROMBOSIS RESEARCH
- Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis
- (2016) Indraraj Umesh Doobaree et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies
- (2016) Wendy J. Langeberg et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors
- (2014) M. Ruggeri et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: Results from a retrospective cohort study
- (2014) Elena Ramírez et al. THROMBOSIS RESEARCH
- Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
- (2013) S. Boyle et al. BLOOD
- Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies
- (2013) Ki-Jo Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immune Thrombocytopenia Patients Requiring Anticoagulation—Maneuvering Between Scylla and Charybdis
- (2013) Axel Matzdorff et al. SEMINARS IN HEMATOLOGY
- Use of Glucocorticoids and Risk of Venous Thromboembolism
- (2013) Sigrun A. Johannesdottir et al. JAMA Internal Medicine
- Antiphospholipid antibodies: Evaluation of the thrombotic risk
- (2012) Katrien M.J. Devreese THROMBOSIS RESEARCH
- Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study
- (2010) R. W. THOMSEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
- (2009) Maria G. Tektonidou et al. ARTHRITIS AND RHEUMATISM
- The ITP syndrome: pathogenic and clinical diversity
- (2009) D. B. Cines et al. BLOOD
- Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients
- (2007) Joseph E. Spahr et al. AMERICAN JOURNAL OF HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now